Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Installed Building Products (IBP) Cash & Equivalents (2016 - 2025)

Installed Building Products' Cash & Equivalents history spans 12 years, with the latest figure at $298.7 million for Q1 2025.

  • For Q1 2025, Cash & Equivalents changed N/A year-over-year to $298.7 million; the TTM value through Mar 2025 reached $298.7 million, changed N/A, while the annual FY2024 figure was $327.6 million, N/A changed from the prior year.
  • Cash & Equivalents for Q1 2025 was $298.7 million at Installed Building Products, down from $327.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $406.2 million in Q3 2024 and bottomed at $191.4 million in Q3 2021.
  • The 5-year median for Cash & Equivalents is $298.7 million (2025), against an average of $287.4 million.
  • The largest YoY upside for Cash & Equivalents was 19.56% in 2024 against a maximum downside of 19.56% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $191.4 million in 2021, then grew by 19.94% to $229.6 million in 2022, then soared by 47.98% to $339.8 million in 2023, then dropped by 3.58% to $327.6 million in 2024, then dropped by 8.82% to $298.7 million in 2025.
  • Per Business Quant, the three most recent readings for IBP's Cash & Equivalents are $298.7 million (Q1 2025), $327.6 million (Q4 2024), and $406.2 million (Q3 2024).